Suppr超能文献

[慢性肾功能不全透析患者的血浆丝氨酸蛋白酶抑制剂]

[Plasma serine protease inhibitors in dialyzed patients with chronic renal insufficiency].

作者信息

Kotschy M, Kassian J, Lampka M, Rajewski W

机构信息

Katedry i Zakładu Patofizjologii A.M. w Bydgoszczy.

出版信息

Pol Merkur Lekarski. 1997 Feb;2(8):93-5.

PMID:9538647
Abstract

In the plasma of fourty dialyzed patients with chronic renal insufficiency in comparison to controls a mild decrease of AT III activity, low activity of PAI-1 and alfa-2 AP with normal activity alfa-2 M. and alfa-1 PI were observed. Hemodialysis with the presence of heparin except of mild shortness of ELT did not influenced the activities of the inhibitors in the plasma of the patients. The decrease of PAI-1 and alfa-2 AP activity with increased FDP concentration in the dialyzed patients can suggests the occurrence of secondary fibrinolysis activation with consumption of these inhibitors.

摘要

与对照组相比,在40例慢性肾功能不全的透析患者血浆中观察到抗凝血酶III(AT III)活性轻度降低、纤溶酶原激活物抑制剂-1(PAI-1)和α2抗纤溶酶(α2 AP)活性较低,而α2巨球蛋白(α2 M)和α1抗胰蛋白酶(α1 PI)活性正常。除了部分凝血活酶时间(ELT)轻度缩短外,在肝素存在下进行血液透析对患者血浆中抑制剂的活性没有影响。透析患者中PAI-1和α2 AP活性降低且纤维蛋白降解产物(FDP)浓度升高,这可能提示这些抑制剂消耗导致继发性纤溶激活的发生。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验